Literature DB >> 24682322

The use of mouse models of breast cancer and quantitative image analysis to evaluate hormone receptor antigenicity after microwave-assisted formalin fixation.

Jesse A Engelberg1, Richard T Giberson, Lawrence J T Young, Neil E Hubbard, Robert D Cardiff.   

Abstract

Microwave methods of fixation can dramatically shorten fixation times while preserving tissue structure; however, it remains unclear if adequate tissue antigenicity is preserved. To assess and validate antigenicity, robust quantitative methods and animal disease models are needed. We used two mouse mammary models of human breast cancer to evaluate microwave-assisted and standard 24-hr formalin fixation. The mouse models expressed four antigens prognostic for breast cancer outcome: estrogen receptor, progesterone receptor, Ki67, and human epidermal growth factor receptor 2. Using pathologist evaluation and novel methods of quantitative image analysis, we measured and compared the quality of antigen preservation, percentage of positive cells, and line plots of cell intensity. Visual evaluations by pathologists established that the amounts and patterns of staining were similar in tissues fixed by the different methods. The results of the quantitative image analysis provided a fine-grained evaluation, demonstrating that tissue antigenicity is preserved in tissues fixed using microwave methods. Evaluation of the results demonstrated that a 1-hr, 150-W fixation is better than a 45-min, 150-W fixation followed by a 15-min, 650-W fixation. The results demonstrated that microwave-assisted formalin fixation can standardize fixation times to 1 hr and produce immunohistochemistry that is in every way commensurate with longer conventional fixation methods.

Entities:  

Keywords:  antigenicity; breast cancer; formalin; microwave; model system; mouse; quantitative image analysis

Mesh:

Substances:

Year:  2014        PMID: 24682322      PMCID: PMC4005368          DOI: 10.1369/0022155414529250

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  17 in total

1.  Novel DNA staining method and processing technique for the quantification of undamaged double-stranded DNA in epidermal tissue sections by PicoGreen probe staining and microspectrophotometry.

Authors:  Claude E Gagna; Hon-Reen Kuo; Norman J Chan; Eugene J Mitacek; Alla Spivak; Tiffany D Pasquariello; Chandrika Balgobin; Ruhayna Mukhi; W Clark Lambert
Journal:  J Histochem Cytochem       Date:  2007-05-28       Impact factor: 2.479

2.  Consensus recommendations on estrogen receptor testing in breast cancer by immunohistochemistry.

Authors:  Hadi Yaziji; Clive R Taylor; Neal S Goldstein; David J Dabbs; Elizabeth H Hammond; Bryan Hewlett; Alton D Floyd; Todd S Barry; Alvn W Martin; Sunil Badve; Frederick Baehner; Richard W Cartun; Richard N Eisen; Paul E Swanson; Stephen M Hewitt; Mogen Vyberg; David G Hicks
Journal:  Appl Immunohistochem Mol Morphol       Date:  2008-12

3.  Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer.

Authors:  P M Siegel; E D Ryan; R D Cardiff; W J Muller
Journal:  EMBO J       Date:  1999-04-15       Impact factor: 11.598

4.  The effect of prolonged fixation on the immunohistochemical evaluation of estrogen receptor, progesterone receptor, and HER2 expression in invasive breast cancer: a prospective study.

Authors:  Leung Chu Tong; Nahid Nelson; Jim Tsourigiannis; Anna Marie Mulligan
Journal:  Am J Surg Pathol       Date:  2011-04       Impact factor: 6.394

Review 5.  Systematic review on hormone receptor testing in breast cancer.

Authors:  Sharon Nofech-Mozes; Emily T Vella; Sukhbinder Dhesy-Thind; Karen L Hagerty; Pamela B Mangu; Sarah Temin; Wedad M Hanna
Journal:  Appl Immunohistochem Mol Morphol       Date:  2012-05

Review 6.  Prognostic and predictive factors in breast cancer by immunohistochemical analysis.

Authors:  D C Allred; J M Harvey; M Berardo; G M Clark
Journal:  Mod Pathol       Date:  1998-02       Impact factor: 7.842

7.  Immunohistochemical assessment of hormone receptor status using a new scoring system (J-Score) in breast cancer.

Authors:  Masafumi Kurosumi
Journal:  Breast Cancer       Date:  2007       Impact factor: 4.239

Review 8.  Current issues in ER and HER2 testing by IHC in breast cancer.

Authors:  Allen M Gown
Journal:  Mod Pathol       Date:  2008-05       Impact factor: 7.842

9.  Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health recurrence score in early breast cancer.

Authors:  Jack Cuzick; Mitch Dowsett; Silvia Pineda; Christopher Wale; Janine Salter; Emma Quinn; Lila Zabaglo; Elizabeth Mallon; Andrew R Green; Ian O Ellis; Anthony Howell; Aman U Buzdar; John F Forbes
Journal:  J Clin Oncol       Date:  2011-10-11       Impact factor: 44.544

Review 10.  American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.

Authors:  M Elizabeth H Hammond; Daniel F Hayes; Mitch Dowsett; D Craig Allred; Karen L Hagerty; Sunil Badve; Patrick L Fitzgibbons; Glenn Francis; Neil S Goldstein; Malcolm Hayes; David G Hicks; Susan Lester; Richard Love; Pamela B Mangu; Lisa McShane; Keith Miller; C Kent Osborne; Soonmyung Paik; Jane Perlmutter; Anthony Rhodes; Hironobu Sasano; Jared N Schwartz; Fred C G Sweep; Sheila Taube; Emina Emilia Torlakovic; Paul Valenstein; Giuseppe Viale; Daniel Visscher; Thomas Wheeler; R Bruce Williams; James L Wittliff; Antonio C Wolff
Journal:  J Clin Oncol       Date:  2010-04-19       Impact factor: 44.544

View more
  3 in total

1.  A Syngeneic ErbB2 Mammary Cancer Model for Preclinical Immunotherapy Trials.

Authors:  Zsófia Pénzváltó; Jane Qian Chen; Clifford G Tepper; Ryan R Davis; Matthew T Silvestrini; Maxine Umeh-Garcia; Colleen Sweeney; Alexander D Borowsky
Journal:  J Mammary Gland Biol Neoplasia       Date:  2019-02-27       Impact factor: 2.673

2.  Elevated Foxp3/CD8 Ratio in Lung Adenocarcinoma Metastatic Lymph Nodes Resected by Transcervical Extended Mediastinal Lymphadenectomy.

Authors:  Joanna Domagala-Kulawik; Iwona Kwiecien; Juliusz Pankowski; Monika Pasieka-Lis; Dominika Wolosz; Marcin Zielinski
Journal:  Biomed Res Int       Date:  2017-08-02       Impact factor: 3.411

3.  Fundamental Concepts for Semiquantitative Tissue Scoring in Translational Research.

Authors:  David K Meyerholz; Amanda P Beck
Journal:  ILAR J       Date:  2018-12-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.